Update date: Jul 22, 2026 | 299 Pages | Report ID: BC-A-009950
Non-Anticoagulant Rodenticides Market
DMA IntelligenceNon-Anticoagulant Rodenticides Growth, Trends & Forecast Outlook 2033
Segments: Product Type (Bromethalin, Cholecalciferol, Zinc Phosphide, Strychnine, Others), Formulation (Pellets, Blocks, Powders, Liquids, Others), Application (Agricultural, Urban, Industrial, Residential, Others), Distribution Channel (Online, Offline), By Region, And Segment Forecasts
$625.0M
Market Size, 2025
$658.8M
Market Estimate, 2026
$951.9M
Market Forecast, 2033
5.4%
CAGR, 2026–2033
Non-Anticoagulant Rodenticides Market Size, Share & Key Insights
The Non-Anticoagulant Rodenticides Market size was valued at USD 625.00 in 2025, and the market is projected to grow from USD 658.75 in 2026 to USD 951.93 by 2033, growing at a CAGR of 5.4%% during the forecast period 2026–2033. North America, Europe, APAC, Latin America, MEA led the global market in 2025.
Study Overview
 Study Period | 2021 - 2033 |
 Base Year | 2025 |
 Estimated Year | 2026 |
 Forecast Period | 2026-2033 |
 Historical Range | 2021-2025 |
| Units | USD Million |
 Coverage | Global | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
 Deliverables | PDF + Excel Data Pack |
Major Market Players
Key Takeaways: Non-Anticoagulant Rodenticides Market
- In 2025, the global Non-Anticoagulant Rodenticides market size was estimated to be USD 625 Million
- Projected to grow at a 5.4% CAGR, reaching a valuation of USD 951.39 Million by 2033
- The Bromethalin category accounted for the highest market share of 40.0% within the Product Type segment
- Cholecalciferol captured a substantial 28.8% of the total revenue in 2025
- Regionally, North America emerged as the top market, generating USD 220 Million and securing a 35.2% share
- Primary market growth drivers include increasing rodent infestations and rising environmental concerns
- Key industry player BASF SE strengthened its market position via strategic product development and distribution network expansion
Market Definiton and Strategic Context
The Non-Anticoagulant Rodenticides Market refers to the global industry engaged in the development, manufacturing, and distribution of rodenticides that do not function by inhibiting blood clotting. These products are crucial for pest control in various settings, offering an alternative to traditional anticoagulant formulations, which have faced scrutiny due to secondary poisoning risks to non-target wildlife and pets. The market encompasses a range of active ingredients such as bromethalin, cholecalciferol, and zinc phosphide, utilized in different formulations like baits, pellets, blocks, and dusts. This market is driven by the persistent global challenge of rodent infestations in agriculture, residential areas, commercial establishments, and industrial facilities, causing significant economic damage, food contamination, and public health risks. The growing awareness regarding environmental safety and the need for effective, targeted pest management solutions are key factors influencing the Non-Anticoagulant Rodenticides market size and its growth outlook. The market is experiencing industry expansion propelled by stringent regulatory frameworks promoting safer pest control practices and increasing demand for rapid-acting, single-dose rodenticides. The global Non-Anticoagulant Rodenticides market was valued at USD 625 Million in 2025, with a robust market forecast indicating continued growth as stakeholders seek sustainable and efficient rodent control strategies.
| Report Attribute | Details |
|---|---|
| Market size value in 2025 | USD 625.00 Million |
| Revenue forecast in 2033 | USD 951.93 Million |
| Growth rate | CAGR of 5.4% from 2025 to 2033 |
| Actual data | 2021 - 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD Million and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | Product Type, Formulation, Application, Distribution Channel |
| Regional scope | North America; Europe; APAC; Latin America; MEA |
| Country scope | All; All; All; All; All |
| Key companies profiled | BASF SE; Bayer AG; Syngenta AG; UPL Limited; Liphatech Inc.; PelGar International; Rentokil Initial plc; Neogen Corporation; Bell Laboratories Inc.; JT Eaton & Co., Inc.; Impex Europa S.L.; FMC Corporation; Senestech, Inc.; Kalyani Industries Ltd.; Sree Ramcides Chemicals Pvt. Ltd.; EcoClear Products; Zapi S.p.A.; Detia Degesch Group; Killgerm Group Ltd.; APC (Animal Pest Control) Australia |
| Customization scope | Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Growth Catalysts & Market Constraints
The Non-Anticoagulant Rodenticides market is currently experiencing significant momentum driven by evolving pest control needs and regulatory shifts. These dynamics are shaping the Non-Anticoagulant Rodenticides market size and influencing its growth forecast, with factors such as increasing rodent resistance to traditional anticoagulants and heightened environmental awareness playing pivotal roles. The industry expansion is also fueled by innovations in formulation and application methods, aiming for greater efficacy and safety. However, the market faces constraints related to product development costs and the need for continuous research to maintain effectiveness against adaptable rodent populations. Understanding these interwoven growth catalysts and market constraints is essential for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities within the Non-Anticoagulant Rodenticides market.
Growth Drivers
- Increasing global rodent infestations, particularly in agricultural and urban areas, drive the demand for effective control measures. These infestations lead to significant crop damage, food spoilage, and public health risks, compelling authorities and individuals to seek potent and reliable rodenticide solutions, thereby fueling market growth for non-anticoagulant options. The economic impact of such damage underscores the critical need for advanced pest management.
- Growing environmental and safety concerns regarding secondary poisoning from anticoagulant rodenticides are pushing the adoption of non-anticoagulant alternatives. Regulatory bodies and consumers increasingly prefer products that pose less risk to non-target wildlife, pets, and the environment, leading to a shift in market preference and fostering innovation in safer, more targeted formulations. This trend is enhancing the market's sustainability profile.
Restraints
- High development costs associated with discovering and commercializing new non-anticoagulant active ingredients pose a significant barrier to market entry and expansion. Extensive research, regulatory testing, and approval processes require substantial financial investment, which can limit the pace of innovation and the introduction of novel products, impacting market competitiveness and product diversity. This cost burden affects smaller players disproportionately.
- The potential for misuse and the development of rodent resistance to existing non-anticoagulant formulations present a continuous challenge. Improper application or over-reliance on a single active ingredient can lead to reduced efficacy over time, necessitating constant product evolution and integrated pest management strategies to maintain control, thereby increasing operational complexities for manufacturers and users alike.
Opportunities
- Expansion into emerging markets, particularly in Asia Pacific and Latin America, offers significant growth opportunities due to rapid urbanization, increasing agricultural output, and rising awareness about pest control. These regions present untapped consumer bases and evolving regulatory landscapes that are increasingly open to advanced pest management solutions, providing a fertile ground for market penetration and revenue growth through strategic partnerships and distribution channels.
- Technological advancements in bait delivery systems, smart traps, and integrated pest management (IPM) solutions can enhance the efficacy and precision of non-anticoagulant rodenticides. Innovations that allow for targeted application, real-time monitoring, and reduced human intervention can create new product categories and value propositions, attracting a broader customer base and solidifying the market's long-term growth trajectory.
Challenges
- Stringent regulatory hurdles and varying approval processes across different countries create complexities for market players. Navigating diverse environmental protection laws, product registration requirements, and labeling standards can prolong market entry timelines and increase compliance costs, impacting global commercialization strategies and the ability to achieve economies of scale. Harmonization of these regulations remains a significant challenge.
- The competition from traditional anticoagulant rodenticides, which are often more cost-effective and have established market presence, continues to challenge the growth of non-anticoagulant alternatives. Overcoming entrenched market habits and demonstrating the superior long-term benefits and environmental safety of non-anticoagulants requires substantial marketing and educational efforts, influencing consumer and professional pest controller adoption rates.
Market Level Breakdown
The Non-Anticoagulant Rodenticides market is primarily segmented by product type, including Bromethalin, Cholecalciferol, Zinc Phosphide, and others. Bromethalin-based products represent the largest share within this segment, valued at USD 250 million in 2025, owing to their rapid action and effectiveness against various rodent species, making them a preferred choice for quick eradication. Cholecalciferol and Zinc Phosphide also hold significant shares, offering distinct mechanisms of action that are critical for managing rodent resistance and providing diverse options for pest control professionals. This segmentation highlights the technological diversity and tailored solutions available in the non-anticoagulant rodenticides market.
Further segmentation by formulation categorizes the market into baits, pellets, blocks, and dusts. Baits dominate the market, capturing approximately 49.6% of the share in 2025, primarily due to their ease of application, palatability to rodents, and sustained effectiveness. Pellets and blocks are also widely used, offering weather resistance and durability, particularly in outdoor or moist environments. Dusts, while smaller in market share, provide specialized application for hard-to-reach areas. The variety in formulations allows for adaptable pest management strategies across different environmental conditions and infestation levels, contributing to the overall Non-Anticoagulant Rodenticides market growth.
The application segment divides the Non-Anticoagulant Rodenticides market into agriculture, residential, commercial, and industrial uses. Agriculture represents the largest application area, driven by the substantial economic losses caused by rodent damage to crops and stored grains. Residential and commercial applications are also significant, fueled by public health concerns and property damage. Industrial facilities, such as food processing plants and warehouses, utilize these rodenticides to comply with hygiene standards and protect inventory. This diverse application base underscores the broad utility and essential role of non-anticoagulant rodenticides in various sectors.
Distribution channel segmentation includes online and offline sales. The offline channel, comprising retail stores, pest control distributors, and agricultural supply stores, holds the majority share, with USD 425 million in 2025, reflecting the traditional purchasing patterns of professional pest controllers and farmers. However, the online distribution channel is experiencing rapid growth, driven by increasing e-commerce adoption and convenience for residential users. The evolving landscape of distribution channels is crucial for market players to reach diverse customer segments and adapt to changing consumer preferences in the Non-Anticoagulant Rodenticides industry.
Non-Anticoagulant Rodenticides Segmentation Breakdown
- Product Type
- Bromethalin
- Cholecalciferol
- Zinc Phosphide
- Strychnine
- Others
- Formulation
- Pellets
- Blocks
- Powders
- Liquids
- Others
- Application
- Agricultural
- Urban
- Industrial
- Residential
- Others
- Distribution Channel
- Online
- Offline
Geographic Performance & Regional Trends
Regionally, North America emerged as the largest market for Non-Anticoagulant Rodenticides in 2025, accounting for 35.2% of the global share with a value of USD 220 million. This dominance is attributed to stringent pest control regulations, high adoption rates of advanced pest management solutions, and significant investments in agricultural and public health infrastructure. Conversely, Asia Pacific is projected to be the fastest-growing market, with a CAGR of 6.5%. The rapid urbanization, increasing agricultural activities, and rising awareness about environmental safety in countries like China and India are key factors fueling this Non-Anticoagulant Rodenticides market growth. The region's expanding industrial and residential sectors also contribute to the rising demand for effective rodent control.
Regional Growth Drivers
- North America: The region's robust regulatory framework, emphasizing reduced environmental impact and targeted pest control, drives the adoption of non-anticoagulant rodenticides. High awareness among consumers and professional pest management services about the risks of secondary poisoning also contributes significantly to market demand in the United States and Canada, fostering continuous product innovation and market expansion.
- Europe: Strict environmental protection policies and a strong focus on sustainable agriculture are key drivers for the non-anticoagulant market in Europe. Countries like Germany, the United Kingdom, and France are actively promoting safer pest control alternatives, leading to increased investment in research and development of environmentally friendly rodenticide solutions. This legislative push accelerates market shift.
- Asia Pacific: Rapid economic growth, expanding agricultural land, and increasing urbanization in countries such as China, India, and Japan fuel significant demand for effective rodent control. The growing awareness about public health threats posed by rodents, coupled with improving pest management infrastructure, positions Asia Pacific as a high-growth region for non-anticoagulant rodenticides.
- Latin America: Modernization of agricultural practices and growing investments in public health programs are boosting the adoption of non-anticoagulant rodenticides in Latin America. Countries like Brazil and Mexico are experiencing increasing demand due to persistent rodent challenges in both rural and urban settings, driving market expansion as awareness of effective solutions rises.
- Middle East & Africa: Improving access to advanced pest control technologies and increasing concerns about food security and hygiene are driving the market in the Middle East & Africa. Governments and agricultural sectors in countries like Saudi Arabia and South Africa are investing in modern pest management solutions, leading to a steady uptake of non-anticoagulant products to protect crops and public health.
The regional forecast indicates a divergence in market trajectories, with mature markets like North America and Europe demonstrating stable growth driven by regulatory compliance and product innovation. In contrast, emerging economies in Asia Pacific and Latin America are poised for accelerated expansion, fueled by increasing agricultural activities, rapid urbanization, and growing environmental awareness. This dynamic creates strategic implications for suppliers, necessitating localized product offerings, tailored distribution strategies, and investments in educational initiatives to capitalize on the distinct opportunities presented by each region. The shift towards safer and more sustainable pest control methods will continue to define global market trends.
Competitive Insights & Leading Companies
The Non-Anticoagulant Rodenticides competitive landscape is characterized by a moderately consolidated structure, with several global and regional players vying for market share. Key players such as BASF SE, Bayer AG, and Syngenta AG, alongside specialized pest control companies, dominate the market, leveraging their extensive research and development capabilities, broad product portfolios, and strong distribution networks. The competitive intensity is driven by continuous innovation in active ingredients and formulation technologies, aiming for enhanced efficacy, faster action, and reduced environmental impact. Companies differentiate themselves through product performance, safety profiles, regulatory approvals, and the ability to offer integrated pest management solutions. Pricing strategies, robust supply chain management, and strong relationships with professional pest control operators and agricultural distributors are also crucial competitive levers. The market sees a mix of large multinational corporations with global reach and smaller, specialized firms focusing on niche applications or specific geographical areas, contributing to a dynamic and evolving competitive environment within the Non-Anticoagulant Rodenticides industry.
Strategic initiatives, including mergers and acquisitions, product launches, and geographical expansions, are frequently observed among leading companies to strengthen their market positions and broaden their product offerings. For instance, companies are investing in R&D to develop new non-anticoagulant compounds that offer improved palatability, faster kill rates, and reduced resistance potential. Partnerships and collaborations with local distributors and research institutions are common strategies to penetrate new markets and enhance product development. Differentiation is achieved through various means, including superior product formulations that offer better weather resistance or ease of application, advanced bait station technologies, and comprehensive technical support for end-users. Some companies focus on providing eco-friendly or organic-certified options to cater to environmentally conscious consumers and regulations. However, challenges such as margin pressure due to intense competition, compliance costs associated with evolving environmental regulations, and the need for continuous product innovation to combat rodent adaptability remain significant. Companies must balance these pressures with the demand for effective and safe rodent control solutions to maintain their competitive edge in the Non-Anticoagulant Rodenticides key players arena.
Non-Anticoagulant Rodenticides Key Companies
- BASF SE
- Bayer AG
- Syngenta AG
- UPL Limited
- Liphatech Inc.
- PelGar International
- Rentokil Initial plc
- Neogen Corporation
- Bell Laboratories Inc.
- JT Eaton & Co., Inc.
- Impex Europa S.L.
- FMC Corporation
- Senestech, Inc.
- Kalyani Industries Ltd.
- Sree Ramcides Chemicals Pvt. Ltd.
- EcoClear Products
- Zapi S.p.A.
- Detia Degesch Group
- Killgerm Group Ltd.
- APC (Animal Pest Control) Australia
Non-Anticoagulant Rodenticides Market Ecosystem
Ecosystem Participants
- Raw Material Suppliers — provide active ingredients (e.g., bromethalin, cholecalciferol, zinc phosphide) and inert components (e.g., cereals, attractants) necessary for formulating rodenticides. Their role is critical in ensuring the quality, availability, and cost-effectiveness of foundational substances, which directly impacts the final product's efficacy and market price. They must adhere to strict quality control and supply chain regulations to meet industry standards.
- Manufacturers/Formulators — develop and produce the final non-anticoagulant rodenticide products in various forms like baits, pellets, blocks, and dusts. This involves extensive R&D to optimize formulations for efficacy, palatability, safety, and environmental impact. They are responsible for compliance with global and regional regulatory requirements, ensuring their products meet performance and safety standards before reaching the market.
- Distributors/Wholesalers — act as intermediaries, connecting manufacturers with a broad network of retailers, professional pest control operators, and agricultural suppliers. They manage logistics, warehousing, and often provide technical support and training on product application. Their efficiency in inventory management and timely delivery is crucial for market penetration and ensuring product availability across diverse geographical regions and customer segments.
- Professional Pest Control Operators (PCOs) — are trained experts who assess infestations, select appropriate non-anticoagulant rodenticides, and apply them safely and effectively in commercial, industrial, and residential settings. They play a vital role in educating end-users on best practices and integrated pest management (IPM) strategies, often driving product preference through their expertise and direct client interaction. Their services are essential for large-scale and complex infestations.
- Retailers (Online & Offline) — provide direct access to non-anticoagulant rodenticides for residential and small-scale agricultural users. This includes hardware stores, garden centers, supermarkets, and e-commerce platforms. Their role involves making products accessible, providing basic product information, and often influencing consumer choice through product placement and promotions. Online channels are increasingly important for convenience and broader reach.
- Agricultural End-Users — farmers and agricultural businesses who utilize non-anticoagulant rodenticides to protect crops, livestock feed, and stored grains from rodent damage. Their purchasing decisions are influenced by product efficacy, cost-effectiveness, and compliance with agricultural safety standards. They often rely on expert advice from PCOs and agricultural suppliers to choose the most suitable products for their specific needs.
- Residential and Commercial End-Users — homeowners, businesses, and public institutions that use rodenticides to control infestations in their premises. Their demand is driven by hygiene concerns, property protection, and public health safety. They seek user-friendly, effective, and safe products, often purchasing through retail channels or hiring professional pest control services for more severe issues. Product safety for children and pets is a key consideration.
- Regulatory Bodies & Environmental Agencies — governmental and non-governmental organizations that establish guidelines, approve products, and monitor the use of rodenticides to ensure safety for humans, animals, and the environment. They play a crucial role in shaping market dynamics by dictating acceptable active ingredients, usage restrictions, and labeling requirements, thereby influencing product innovation and market access for manufacturers.
- Research & Development Institutions — academic and private research organizations focused on discovering new active ingredients, improving existing formulations, and studying rodent behavior and resistance patterns. Their work is fundamental to the long-term sustainability and effectiveness of the non-anticoagulant rodenticides market, providing scientific insights that drive product development and innovation.
Report Coverage & Key Deliverables
The report delivers a comprehensive analysis of the Non-Anticoagulant Rodenticides, combining quantitative data with qualitative insights. It offers a detailed examination of the market's current size, historical trends, and future growth projections, providing stakeholders with a clear understanding of the industry's trajectory. This includes an in-depth assessment of market dynamics, identifying key growth drivers, restraints, opportunities, and challenges that influence the Non-Anticoagulant Rodenticides market. The report also provides a granular breakdown of market segments by product type, formulation, application, and distribution channel, enabling businesses to pinpoint lucrative areas and tailor their strategies effectively. Furthermore, a thorough regional analysis highlights market performance across major geographies, offering insights into regional growth drivers and competitive landscapes. The competitive section profiles leading companies, analyzing their strategies, product portfolios, and recent developments to help clients benchmark their performance and identify potential partners or competitors. This holistic approach ensures decision-makers receive actionable intelligence to navigate the complexities of the Non-Anticoagulant Rodenticides market.
Report Coverage
- Market Size Estimates (historical and forecast)
- Our market size estimates cover the period from 2021 to 2033, providing both historical data for 2021-2025 and a comprehensive forecast spanning 2026-2033. This extensive coverage is derived through a robust methodology involving primary and secondary research, triangulating data points from industry associations, company reports, and expert interviews to ensure accuracy and reliability.
- Detailed Segmentation And Revenue Analysis
- The report offers an in-depth segmentation of the market by product type, formulation, application, and distribution channel, providing revenue figures for each sub-segment. This granular analysis allows stakeholders to understand the market's intricate structure, identify high-growth segments, and assess their revenue potential, facilitating targeted investment and strategic planning decisions.
- Regional And Country-Level Insights
- We provide comprehensive insights into the Non-Anticoagulant Rodenticides market performance across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, including key country-level data. This analysis highlights regional market maturity, growth drivers, regulatory landscapes, and competitive dynamics, enabling businesses to formulate effective regional market entry and expansion strategies.
- Competitive Benchmarking Of Key Players
- The competitive landscape section includes profiles of leading market participants, offering a detailed assessment of their business strategies, product portfolios, financial performance, and recent strategic developments. This benchmarking helps clients understand the competitive intensity, identify key differentiators, and evaluate potential partnership or acquisition opportunities within the industry.
- Customization Options Based on Specific Requirements
- Our reports are highly customizable to meet specific client needs, allowing for adjustments in scope, regional focus, segmentation depth, and company profiling. Whether it's a deep dive into a particular country's market dynamics or an expanded analysis of a specific product category, we offer flexible options to ensure the research perfectly aligns with strategic objectives and delivers maximum value.
Recent Industry Insights
The Non-Anticoagulant Rodenticides industry trends over the past 12-18 months reflect a strong emphasis on product innovation, sustainability, and strategic collaborations. Manufacturers are increasingly focused on developing formulations with enhanced efficacy and improved safety profiles to meet evolving regulatory standards and consumer demands for environmentally friendly pest control. There's a noticeable shift towards integrated pest management (IPM) solutions that combine non-anticoagulant chemicals with non-chemical methods, driven by a holistic approach to pest control. Furthermore, regional expansions and partnerships, particularly in high-growth markets like Asia Pacific, indicate efforts to broaden market reach and capitalize on increasing urbanization and agricultural intensification. These developments underscore the industry's commitment to addressing persistent rodent challenges while prioritizing safety and ecological balance in the Non-Anticoagulant Rodenticides market.
Key Market Developments
- October 2024: Liphatech Inc. announced the launch of a new non-anticoagulant rodenticide bait designed for enhanced palatability and rapid action in professional pest control applications.
- August 2024: Bell Laboratories Inc. expanded its distribution network in Southeast Asia, aiming to increase the availability of its non-anticoagulant product lines to agricultural and commercial sectors.
- May 2024: Regulatory authorities in the European Union introduced updated guidelines favoring non-anticoagulant rodenticides, further restricting the use of certain anticoagulant compounds in outdoor settings.
- February 2024: Senestech, Inc. reported positive field trial results for its fertility-control rodenticide technology, offering a non-lethal, sustainable approach to managing rodent populations, marking a significant innovation in the non-anticoagulant space.
- November 2023: BASF SE partnered with a leading pest management service provider in India to co-develop and market new non-anticoagulant solutions tailored for the region's diverse climate and pest challenges.
Analyst Opinion
The Non-Anticoagulant Rodenticides market outlook remains highly positive, driven by a confluence of environmental concerns, increasing rodent resistance to traditional methods, and stringent regulatory pressures. Analysts observe a growing market attractiveness, particularly for innovative formulations that offer both efficacy and reduced risk to non-target species. The competitive intensity, while moderate, fosters continuous product development and strategic partnerships, pushing the industry towards more sustainable and targeted solutions. Demand-supply balance is generally stable, though regional variations exist, with robust demand in agricultural powerhouses and urban centers. The shift away from first and second-generation anticoagulants presents a significant opportunity for non-anticoagulant alternatives to capture greater market share, provided they can consistently deliver on performance expectations and cost-effectiveness. This dynamic environment necessitates agile strategies from market players to adapt to evolving regulations and consumer preferences, ensuring long-term growth and market leadership in the Non-Anticoagulant Rodenticides sector.
Looking ahead, the long-term outlook for the Non-Anticoagulant Rodenticides market is robust, underpinned by ongoing innovation in active ingredients and delivery systems. The innovation landscape is characterized by research into novel compounds with unique modes of action and the integration of smart technologies for monitoring and precise application. Key risk factors include the potential for new forms of rodent resistance to non-anticoagulants, which would necessitate continuous R&D investment, and the challenge of managing diverse regulatory landscapes globally. Furthermore, the economic viability of new, often more expensive, non-anticoagulant solutions compared to older, cheaper alternatives could pose a barrier to adoption in price-sensitive markets. Strategic implications for companies involve prioritizing sustainable product development, investing in comprehensive educational campaigns for end-users, and forging strong collaborations across the value chain to mitigate risks and capitalize on the expanding demand for safer and more effective rodent control solutions.